Peregrine Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Peregrine Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$7.72 - $12.81 $4.69 Million - $7.79 Million	-607,868 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$9.51 - $16.6 $34,473 - $60,175	-3,625 Reduced 0.59%	607,868 $6.98 Million
Q3 2018 Oct 18, 2018	BUY	$13.05 - $19.05 $57,811 - $84,391	4,430 Added 0.73%	611,493 $0
Q2 2018 Jul 12, 2018	BUY	$13.9 - $19.8 $2.87 Million - $4.09 Million	206,657 Added 51.61%	607,063 $0
Q1 2018 Apr 16, 2018	BUY	$16.7 - $26.35 $6.69 Million - $10.6 Million	400,406 New	400,406 $0

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $133M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.